Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT05964179 Completed - Clinical trials for Nutritional and Metabolic Diseases

Effects of Daily Eating Duration on Health

Start date: March 8, 2023
Phase: N/A
Study type: Interventional

This study would recruit about 50 healthy adult women and randomly divide the participants into two groups for a ten-week crossover intervention study. The investigators aimed to observe the impact of daily feeding/fasting time on clinical metabolic biomarkers.

NCT ID: NCT05963334 Completed - Clinical trials for Advanced Epithelial Ovarian Cancer

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Start date: January 1, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of the current study is to compare weekly versus three-week collective of carboplatin/paclitaxel in advanced epithelial ovarian cancer. The author's hypothesis was to study and correlate routine laboratory tests, clinical biomarkers and quality of life questionnaires between weekly and three-week standard carboplatin regimens in order to reveal any possible superiority for the weekly study arm.

NCT ID: NCT05962125 Completed - Clinical trials for Postoperative Pulmonary Complications

The Role of Periodic Alveolar Recruitment Maneuvers in Intraoperative Protective Ventilation

REMAIN-2
Start date: August 21, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare three open-lung strategies on respiratory function and lung injury in protective ventilation for laparoscopic anterior resection. It aims to answer whether a periodic alveolar recruitment maneuvers (PARM) strategy alone was an appropriate open-lung strategy in intraoperative protective ventilation. Patients were randomly assigned (1:1:1) to receive one of three open-lung strategies in protective ventilation: PARM alone (alveolar recruitment maneuvers [ARM] repeated every 30 min), positive end-expiratory pressure (PEEP) alone (a PEEP of 6 to 8 cm H2O), or a combination of PEEP and PARM (a PEEP of 6 to 8 cm H2O combined with ARM repeated every 30 min). The primary outcome is the mechanical power before the end of intraoperative mechanical ventilation. Secondary outcomes included the accumulative intraoperative mechanical power, an arterial partial pressure of oxygen (PaO2) / inhaled oxygen concentration (FiO2) ratio (P/F ratio) before the end of intraoperative mechanical ventilation, the rates of respiratory failure at post-anesthesia care unit (PACU) and three postoperative days, the concentration of soluble advanced glycation end products receptor (sRAGE) and Clara cell protein 16 (CC16) at the end of surgery, postoperative pulmonary complications score, postoperative hospitalization days and so on.

NCT ID: NCT05960786 Completed - Vertigo Clinical Trials

Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand

Start date: February 2, 2023
Phase: N/A
Study type: Interventional

The goal of this virtual clinical trial is to determine the effectiveness of two study devices in providing temporary relief to adults aged 18-70 who suffer from symptoms of chronic vertigo. The main question[s] it aims to answer are: - Which device do participants respond better to (that is, find more relief)? - To what degree do participants find relief? Participants will be: - Enrolled up to 49 days; 14 days in Baseline Phase (no device) and 21 days in Treatment Phase (study device) for Study Arm 1 or 28 days in Treatment Phase (study device) for Study Arm 2 - Randomized and stratified into groups based on diagnosis to be assigned a study device - Asked to use the study device as instructed by the study coordinator - Asked to download a study app to submit daily diaries regarding their symptoms and use of device, and to participate in tele-health visits with study coordinators - Asked to provide their vertigo diagnosis from their physician - Compensated for their participation Researchers will compare the randomized groups to see which groups respond better to which device.

NCT ID: NCT05956561 Completed - Clinical trials for Endosseous Dental Implant Failure

Correlation Between Vitamin D Serum Level and Early Implant Failure

EDIF
Start date: September 20, 2020
Phase:
Study type: Observational

The goal of this observational study is to investigate relation between serum vitamin D levels and early implant failure. in all patient seeking delayed dental implant placement at Faculty of Dentistry, Ain Shams University from September 2020 to April 2023, all the patients must fulfil the inclusion criteria including age above 18, no medical condition interference and compliance to study. The main question[s] it aims to answer are: - is vitamin D deficiency caustic to early implant failure - can implant stability indicate implant failure Participants will receive implants and prosthetic rehabilitated according to each case.

NCT ID: NCT05955872 Completed - Clinical trials for Focal Segmental Glomerulosclerosis (FSGS)

A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147

Start date: July 19, 2023
Phase: Phase 1
Study type: Interventional

The purpose of the study is to evaluate the relative bioavailability (BA) and the effect of food on the pharmacokinetics (PK), and the safety and tolerability of VX-147 test tablet formulation.

NCT ID: NCT05952089 Completed - Clinical trials for Heart Failure With Reduced Ejection Fraction

A Study to Assess the Effect of Danicamtiv on the Drug Levels of Midazolam in Participants With Stable Heart Failure

Start date: August 17, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is assess the effect of danicamtiv, as an inducer on the drug levels of midazolam in participants with heart failure with reduced ejection fraction (HFrEF).

NCT ID: NCT05950568 Completed - Cesarean Section Clinical Trials

Quadratus Lumborum Block Type III Versus Type II Versus Transversus Abdominis Plane Block in Cesarean Section

Start date: March 24, 2023
Phase: N/A
Study type: Interventional

Compare the type III and type II quadratus lumborum block (QLB) to transversus abdominis plane block (TAPB) regarding efficacy in CS

NCT ID: NCT05950399 Completed - Clinical trials for Malignant Solid Neoplasm

Stress Echocardiography to Identify Chemotherapy Induced Cardiotoxicity in Cancer Patients With Heart Failure Risk

Start date: June 29, 2015
Phase: N/A
Study type: Interventional

This clinical trial evaluates changes in cardiac (heart) function during stress echocardiography to screen for chemically induced cardiotoxicity in cancer patients at a high risk for developing heart failure. Some chemotherapeutic agents to treat certain types of cancers can induce cardiac dysfunction and heart failure. Currently there is no validated means of predicting which patients will go on to develop cardiac toxicity and heart failure following treatment with chemotherapeutic agents. Stress echocardiography is a test that uses ultrasound imaging to show how well the heart muscle is working to pump blood to the body during low intensity exercise. Stress echocardiography prior to and during cancer treatment may help doctors find cancer therapeutic related cardiac dysfunction sooner when it may be easier to treat.

NCT ID: NCT05949515 Completed - Clinical trials for Acute ST Segment Elevation Myocardial Infarction

Retrospective Evaluation of SuperSaturated Oxygen (SSO2) Therapy Clinical Utility

RESCU
Start date: July 31, 2023
Phase:
Study type: Observational

The purpose of this multicenter study is to assess the impact of SSO2 treatment on clinical outcomes and left ventricular function in patients following acute ST-segment elevation myocardial infarction (STEMI).